NARB

National Advertising Review Board

NARB Recommends Ocean Spray Discontinue Broadcast Claims Challenged by Campbell

A NARB panel has recommended that Ocean Spray Cranberries, Inc., discontinue claims challenged by Campbell Soup Company, maker of V8 Vegetable Juice.

Read More

NARB Recommends Fair Trade USA Modify Composite-Products Seal to Better Inform Consumers of ‘Fair-Trade’ Sourced Content

A National Advertising Review Board (NARB) panel has recommended that Fair Trade USA – formerly TransFair – require users of the organization’s “Fair Trade Certified” seal for composite products to provide additional information to consumers.

Read More

NARB Recommends Colgate Discontinue Certain Advertising Claims for ‘Sensitive Pro-Relief’ Toothpaste

A National Advertising Review Board (NARB) panel has recommended that Colgate-Palmolive Company discontinue certain advertising claims for Sensitive Pro-Relief toothpaste, including claims of “faster” relief.

Read More

NARB Recommends Biologic Solutions Discontinue Challenged Advertising Claims for ‘Stem Cell Therapy Skin Cream’

A National Advertising Review Board (NARB) panel has recommended that Biologic Solutions, Inc., discontinue certain advertising claims and “before and after” depictions for the company’s “Stem Therapy Skin Cream.”

Read More

Staff Biographies – NARB

To reach a member of the National Advertising Review Board staff, please contact Sarah Agler, sagler(at)asrc.bbb.org, 212.705.0115

Read More

NARB PANEL RECOMMENDS NOVARTIS DISCONTINUE CLAIMS THAT EXCEDRIN STARTS RELIEVING HEADACHE PAIN FASTER THAN ADVIL Claims at Issue Challenged by Pfizer Consumer Healthcare

New York, New York – Jan. 24,   2012 – A National Advertising Review Board (NARB) panel has recommended that Novartis Consumer Health, Inc., discontinue advertising claims that the company’s Excedrin Extra Strength product starts relieving headache pain faster than Advil. The claims at issue were initially challenged before the National Advertising Division (NAD) of the Council of Better Business Bureaus by Pfizer Consumer Healthcare, the maker of Advil. NAD determined that Novartis did not provide a reasonable basis to support claims that Excedrin starts to relieve headache pain...

Read More